Apparent diffusion coefficient modifications in assessing gastro-oesophageal cancer response to neoadjuvant treatment: comparison with tumour regression grade at histology

[1]  Karin Haustermans,et al.  Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results. , 2012, International journal of radiation oncology, biology, physics.

[2]  Lei Tang,et al.  Early evaluation of cancer response by a new functional biomarker: apparent diffusion coefficient. , 2011, AJR. American journal of roentgenology.

[3]  H. Matsubara,et al.  Apparent Diffusion Coefficient Values Measured by Diffusion-Weighted Imaging Predict Chemoradiotherapeutic Effect for Advanced Esophageal Cancer , 2011, Digestive Surgery.

[4]  K. Ang,et al.  Head and Neck Cancers , 2011 .

[5]  Jae Young Lee,et al.  Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer , 2011, European Radiology.

[6]  Jian Li,et al.  Gastrointestinal stromal tumors treated with imatinib mesylate: apparent diffusion coefficient in the evaluation of therapy response in patients. , 2011, Radiology.

[7]  Woo Kyung Moon,et al.  Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. , 2010, Radiology.

[8]  Vicky Goh,et al.  The role of functional imaging in colorectal cancer. , 2010, AJR. American journal of roentgenology.

[9]  V. Harry Novel imaging techniques as response biomarkers in cervical cancer. , 2010, Gynecologic oncology.

[10]  A. Crucitti,et al.  Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. , 2009, Radiology.

[11]  F. Gilbert,et al.  Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. , 2008, Gynecologic oncology.

[12]  L. Shen,et al.  Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. , 2008, Radiology.

[13]  Bernd Hamm,et al.  Diffusion‐weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft‐tissue sarcomas , 2008, Journal of magnetic resonance imaging : JMRI.

[14]  D. Gotley,et al.  Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus. , 2008, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[15]  D. Collins,et al.  Predicting response of colorectal hepatic metastasis: value of pretreatment apparent diffusion coefficients. , 2007, AJR. American journal of roentgenology.

[16]  Bradford A Moffat,et al.  Prospective Early Response Imaging Biomarker for Neoadjuvant Breast Cancer Chemotherapy , 2007, Clinical Cancer Research.

[17]  H. Christiansen,et al.  Histomorphological tumor regression grading of esophageal carcinoma after neoadjuvant radiochemotherapy: which score to use? , 2006, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[18]  C. V. D. van de Velde,et al.  Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. , 2006, The New England journal of medicine.

[19]  A R Padhani,et al.  Diffusion-weighted MRI: a new functional clinical technique for tumour imaging. , 2006, The British journal of radiology.

[20]  J. Plukker,et al.  Role of positron emission tomography in the (re-)staging of oesophageal cancer , 2006, Scandinavian journal of gastroenterology. Supplement.

[21]  E. Venkatraman,et al.  The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. , 2005, International journal of radiation oncology, biology, physics.

[22]  Nils Lehmann,et al.  Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. Schwaiger,et al.  Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Jürgen Griebel,et al.  Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. , 2003, European journal of radiology.

[25]  A R Padhani,et al.  Functional MRI for anticancer therapy assessment. , 2002, European journal of cancer.

[26]  Jan Wolber,et al.  Diffusion MRI for prediction of response of rectal cancer to chemoradiation , 2002, The Lancet.

[27]  M. Schwaiger,et al.  Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma: Response Evaluation by Positron Emission Tomography , 2001, Annals of surgery.

[28]  M. van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors , 2000, Journal of the National Cancer Institute.

[29]  H. Stein,et al.  Classification of adenocarcinoma of the oesophagogastric junction , 1998, The British journal of surgery.

[30]  K. Chu,et al.  Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. , 1997, The Journal of thoracic and cardiovascular surgery.

[31]  J. Petiot,et al.  Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations , 1994, Cancer.

[32]  A. Maastricht Tumour ADC measurements in rectal cancer:effect of ROI methods on ADC values and interobserver variability , 2012 .

[33]  K. Markou,et al.  National Comprehensive Cancer Network (NCCN) Head and Neck Cancers NCCN Clinical Practice Guidelines in Oncology . 2010. , 2011 .

[34]  A. Sendler Metabolic response evaluation by PET during neoadjuvant treatment for adenocarcinoma of the esophagus and esophagogastric junction. , 2010, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[35]  Lei Tang,et al.  Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. , 2010, Radiology.

[36]  Thomas E Yankeelov,et al.  Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. , 2007, Magnetic resonance imaging.

[37]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[38]  M Van Glabbeke,et al.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. , 2000, Journal of the National Cancer Institute.

[39]  J. Merrill,et al.  Cancer of the vulva , 1961, Cancer.